D. Göppner, J. Müller, S. Krüger, I. Franke, H. Gollnick, and S. R. Quist, “High Incidence of Naevi-associated BRAF Wild-type Melanoma and Dysplastic Naevi under Treatment with the Class I BRAF Inhibitor Vemurafenib”, Acta Derm Venereol, vol. 94, no. 5, pp. 517–520, Feb. 2014.